Diabetes treatment lowers PromarkerD risk score: Results presented at Australasian Diabetes Congress
Proteomics International Laboratories Ltd (Proteomics International; ASX: PIQ) is pleased to...
Related posts
Latest PromarkerD clinical validation results published in the Journal of Diabetes and its...
Medical technology company Proteomics International (ASX: PIQ) has teamed up with biotech stock...